Lithuania: Nucleic Acids Market 2024

Nucleic Acids Market Size in Lithuania

In 2022, the Lithuanian nucleic acids market decreased by -11.7% to $X, falling for the fifth year in a row after four years of growth. Overall, consumption saw a abrupt descent. As a result, consumption attained the peak level of $X. From 2018 to 2022, the growth of the market failed to regain momentum.

Nucleic Acids Production in Lithuania

In value terms, nucleic acids production dropped significantly to $X in 2022 estimated in export price. In general, production, however, showed significant growth. The growth pace was the most rapid in 2015 when the production volume increased by 50,687% against the previous year. Over the period under review, production attained the peak level at $X in 2021, and then contracted remarkably in the following year.

Nucleic Acids Exports

Exports from Lithuania

After three years of growth, overseas shipments of nucleic acids and their salts decreased by -52.6% to X tons in 2022. Over the period under review, exports, however, continue to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 when exports increased by 125%. Over the period under review, the exports attained the peak figure at X tons in 2021, and then dropped markedly in the following year.

In value terms, nucleic acids exports fell to $X in 2022. In general, exports, however, saw a significant increase. The pace of growth was the most pronounced in 2021 with an increase of 208%. As a result, the exports attained the peak of $X, and then shrank in the following year.

Exports by Country

The United States (X tons), Germany (X tons) and the Netherlands (X tons) were the main destinations of nucleic acids exports from Lithuania, together accounting for 71% of total exports. China, Russia, Switzerland, Japan and Uzbekistan lagged somewhat behind, together comprising a further 21%.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Switzerland (with a CAGR of +159.5%), while the other leaders experienced more modest paces of growth.

In value terms, the largest markets for nucleic acids exported from Lithuania were the United States ($X), Germany ($X) and Switzerland ($X), together comprising 78% of total exports.

Among the main countries of destination, Switzerland, with a CAGR of +175.7%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average nucleic acids export price stood at $X per kg in 2022, surging by 92% against the previous year. Over the period under review, the export price enjoyed a significant expansion. The most prominent rate of growth was recorded in 2021 an increase of 166%. Over the period under review, the average export prices hit record highs in 2022 and is expected to retain growth in the immediate term.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Switzerland ($X per kg), while the average price for exports to China ($X per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Uzbekistan (+80.8%), while the prices for the other major destinations experienced more modest paces of growth.

Nucleic Acids Imports

Imports into Lithuania

In 2022, imports of nucleic acids and their salts into Lithuania totaled X tons, with an increase of 5% against 2021 figures. In general, imports recorded a significant expansion. The pace of growth appeared the most rapid in 2013 when imports increased by 386% against the previous year. Imports peaked at X tons in 2018; however, from 2019 to 2022, imports failed to regain momentum.

In value terms, nucleic acids imports surged to $X in 2022. Overall, imports enjoyed significant growth. The pace of growth appeared the most rapid in 2017 when imports increased by 227%. Imports peaked in 2022 and are likely to see gradual growth in years to come.

Imports by Country

In 2022, Germany (X tons) constituted the largest supplier of nucleic acids to Lithuania, with a 54% share of total imports. Moreover, nucleic acids imports from Germany exceeded the figures recorded by the second-largest supplier, Italy (X tons), twofold. The United States (X tons) ranked third in terms of total imports with a 9.7% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Germany amounted to +38.3%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (+76.4% per year) and the United States (+53.4% per year).

In value terms, the United States ($X) constituted the largest supplier of nucleic acids and their salts to Lithuania, comprising 79% of total imports. The second position in the ranking was held by China ($X), with a 9.8% share of total imports. It was followed by Germany, with a 4.7% share.

From 2012 to 2022, the average annual rate of growth in terms of value from the United States stood at +72.5%. The remaining supplying countries recorded the following average annual rates of imports growth: China (+42.1% per year) and Germany (+38.4% per year).

Import Prices by Country

In 2022, the average nucleic acids import price amounted to $X per ton, jumping by 92% against the previous year. In general, the import price saw a significant expansion. The growth pace was the most rapid in 2019 an increase of 208% against the previous year. The import price peaked in 2022 and is likely to continue growth in the near future.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X per ton), while the price for Italy ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Slovakia (+78.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform